IMT: infinitus Medical Technologies

08/29/2026

A 12 × 80-inch draw sheet is being asked to do two jobs it was never designed for: lift and move an anesthetized patient into lithotomy, then tuck the arms.

Those are separate failure modes. One sheet, too narrow, used as a transfer device and as a restraint. That combination is still treated as standard of care by the market leader in Trendelenburg positioning.

does not treat those jobs as one small drawsheet problem. Ergonomic Tool #1 limits draw-sheet-only lateral transfers or lifts: above about 157 lb, a pull with sheet alone exceeds the 35-lb sustained-force model and requires an assistive device (air, low/high friction combination decice), a mechanical transfer device, or a lift. Positioning guidance then requires a clean arm tuck: palms in, elbows not hyperextended, sheet between the patient and the mattress, not under it.

One 12-inch drawsheet cannot satisfy both.

That width is not an accident. The market leader’s lift sheets are cut 12 × 80–84 inches and parked in the lumbar span so the sacrum and scapulae sit on exposed foam. The commercial claim is that the patient must sink into those two contact patches, and that indentation is what keeps them from sliding in steep Trendelenburg and lithotomy.

Indentation is not a substitute for friction coefficient × contact area. Optimized friction interface and accountability for adipose and skin elasticity is key to efficacy. So is reinforcement of the pad to eliminate elongation and tears, which contribute to skin shearing and migrations.

A few square inches of compressed foam under two bony landmarks is a small interface. A 12-inch drawsheet between those landmarks does not add area; it subtracts it. It also cannot cradle the torso for a lithotomy transfer: the sheet is off the pelvis and scapulae by design, so the pull is a cinch through lumbar soft tissue. After that drag, the same wrinkled strap is asked to wrap both arms.

The physics that actually resist migration in Trendelenburg and lithotomy are high friction over a large, continuous surface, not two foam wells plus a drawsheet.

already separated transfer from positioning. The kit that still uses one 12 × 80 sheet for both is optimizing pad exposure, not handling or tuck safety. Pad exposure means optimized traction and stability, its physics!

Let us undo more than 20 years of a process that was adopted because the product was designed that way, not because AORN or biomechanics said it was safe.

06/19/2026

Three distinct pathways. One massive evolution in care.

Our design delivers proven operational efficiency, with documented VAC approvals showing an average reduction of 17 to 25 minutes in robotic docking times at major robotic epicenter.

Handle your patients less, and care more.

Infinitusmedical.com

06/05/2026

The existence of Bigfoot 🫈 is more believable than biodegradable foam products in healthcare. Biodegradable foam in healthcare settings is one of the more persistent myths in medical supply marketing, and the science behind the claims rarely survives scrutiny.

Here is why.

The primary certification cited by biodegradable foam manufacturers is ASTM D5511, a lab standard designed to simulate bioreactive landfill conditions — elevated temperatures, high moisture content, and active microbial environments. The problem: that environment describes roughly 1 to 3% of U.S. landfills.

The remaining 97 to 99% are “dry tomb” landfills. These facilities are EPA engineered specifically to prevent groundwater leachate migration, which means they are lined and sealed. Moisture is minimized by design. In that environment, organic and biodegradable materials do not fully decompose. They partially break down, generating methane and CO2 that must be actively captured, a requirement most landfills do not meet.

The emissions calculus matters for healthcare facilities as well. Regulated medical waste disposal follows one of three pathways: incineration, which is relatively rare; bioreactive processing; or dry tomb landfill. In each case, facilities choosing biodegradable foam will see Scope 3 emissions increase relative to conventional products that simply become carbon-locked in place. The biodegradable designation does not alter that outcome, it only alters the price paid.

The bottom line: a biodegradable foam pad and a conventional foam pad will share the same landfill cell and decompose at roughly the same rate under real-world disposal conditions. The certification language is technically accurate in a lab. It is not accurate in practice.

Do not pay a sustainability premium for a claim that does not survive the disposal pathway your facility actually uses.

To understand the regulatory reality of medical waste disposal and which standards actually apply, please consider reading: https://www.dropbox.com/scl/fi/ftrgwz87v47p3pj4jkoyd/Medical-Waste-Disposal-Sustainability-and-Greenwashing-2026.pdf?rlkey=xi4ke9mxgwf1jarm53e0hy26w&st=yw2h8w8z&dl=0

03/27/2026

A note to eco-conscious surgical teams: It’s time to look past the marketing hype surrounding "biodegradable" positioning pads and examine the facts.

To effectively evaluate healthcare’s environmental footprint or sustainability initiatives, one must first master the complexities of the regulated medical waste (RMW) disposal lifecycle.

Don't let marketed ASTM D5511 standards mislead you. While vendors use them to claim biodegradability, these tests only apply to the simulated lab conditions of a tiny fraction of U.S. landfills, commonly known as “Bioreactive”.

The overwhelming majority, 97% to 99% of landfills, are 'dry tombs' designed to prevent decomposition and lock away solids (carbon locking). Without this context, 'biodegradable' is just a marketing term, not a functional reality. You’re paying more to feel better with very little to no environmental benefit. In fact, you could be making your hospital’s Scope 3 emissions worse!

A counterintuitive but scientifically important point: in a dry tomb landfill, a product marketed as biodegradable may actually produce worse greenhouse gas outcomes than a stable, non-degrading alternative. Here is why.

Anaerobic decomposition is the only pathway available in oxygen-limited landfills and it produces methane (CH₄) as a primary byproduct. Methane is a potent greenhouse gas with a global warming potential 25 to 80 times greater than CO₂ over 20 to 100-year time horizons.

If a product partially degrades in a dry tomb landfill:

• It converts some of its carbon into methane during that partial decomposition.

• If the landfill lacks an effective methane capture and energy recovery system, as is common in many facilities, and that methane escapes into the atmosphere as a fugitive emission.

• Even well-designed gas capture systems collect only approximately 75% of landfill gas emissions under ideal conditions, with collection efficiency declining over time.

Here’s a comprehensive document that explains exactly what happens to your surgical waste when it leaves your OR. We explain treatment, and the vast differences in Municipal Landfill designs under the EPA.

Cheers.

Shared with Dropbox

02/21/2026

Eco-conscious hospitals and healthcare providers need to closely examine “biodegradable” foam pad claims, especially when manufacturers rely on ASTM D5511, a standard relevant to just ~1% of U.S. landfills.

Here’s what you need to know before paying that extra premium at face value:

https://infinitusmedical.com/are-you-being-greenwashed-assessing-biodegradation-claims-in-memory-foam-positioning-products-a-questionnaire-for-healthcare-professionals/

02/19/2026

The more you understand biodegradable foam marketing claims and the ASTM standards frequently cited in them, the better you can spot what's legitimate versus potentially misleading or greenwashed.

Regulators such as the FTC have determined that results from ASTM D5511 alone cannot support unqualified claims that a product is "biodegradable." This is because the test does not demonstrate complete decomposition under typical real-world landfill conditions or common disposal scenarios. Moreover, biodegradation in such environments often plateaus well short of full mineralization.

To clarify the context, most U.S. landfills (approximately 95-99%) operate as "dry tomb" landfills. These facilities are designed to minimize moisture infiltration, using liners, covers, and leachate management systems, to isolate waste and reduce environmental risks like groundwater contamination. As a result, they create dry, anaerobic conditions where biological degradation of materials (including plastics) occurs very slowly, if at all, over decades or more.

In contrast, "bioreactive" (or "wet" / bioreactor) landfills represent only a small fraction (1-5%) of landfills. These actively manage moisture (often through leachate recirculation) to accelerate microbial activity, promoting faster waste stabilization and gas production. ASTM D5511 is an accelerated high-solids anaerobic test that better simulates the biologically active, higher-moisture conditions found in these rare bioreactive landfills—not the predominant dry tomb environments where most waste ends up.

For accurate and substantiated "biodegradable" claims in typical disposal scenarios, testing must better replicate actual landfill conditions (e.g., using methods like ASTM D5526 for varying moisture levels), and claims should be qualified accordingly to avoid misleading consumers.

In the healthcare industry, sustainability efforts increasingly focus on single-use medical devices, including memory foam-based patient positioning pads used in operating rooms for procedures requiring Trendelenburg or other specialized positions. These pads help prevent patient sliding, reduce pre...

02/18/2026

Every manual lift by hand and draw-sheet of a patient adds cumulative ergonomic risk to your team’s safety, leading to musculoskeletal injuries, back strain, and long-term harm for perioperative staff.

Yet every time you pre-position a patient into lithotomy to avoid those risks, you’re introducing anesthesia airway challenges and complications for the patient. The anesthesia airway is the most critical first step in safe surgical care.

The “standard of care” this industry has accepted is far from truly safe or optimal for either side.



We can help: infinitusmedical.com

02/18/2026

The way the industry has positioned surgical patients, particularly in robotic procedures, has never truly been “normal” or optimal. We can help in ways no other company can: infinitusmedical.com

02/18/2026

The way the industry has positioned surgical patients, particularly in robotic procedures, has never truly been “normal” or optimal. We can help in ways no other company can: infinitusmedical.com

Surgical positioning platforms should guide standardized care processes and deliver high reliability every time. They have to balance patient safety and surgical staff safety, no compromises.

We’re definitely not your average overproduced commodity pad.